文献速递妇科

Swedescore 系统评分法与传统阴道镜检测 CIN2+ 的诊断准确性比较:多中心非随机临床研究

Diagnostic accuracy of a systematic approach using Swedescore versus conventional colposcopy for the detection of cervical intraepithelial neoplasia grade 2 or worse: A multicenter, non‐randomized clinical study
RSS 订阅 · Acta Obstetricia et Gynecologica Scandinavica · 2026-11-04

这项多中心非随机临床研究纳入 929 名转诊阴道镜且转化区可见的女性,比较系统使用 Swedescore 与传统阴道镜检测 CIN2+ 的诊断准确性。Swedescore 组敏感性 84.7%、特异性 37.3%,传统组分别为 77.8%、30.9%,前者略高,但需考虑两组基线不平衡。

要点

  • Swedescore 系统评分法较传统阴道镜略微提高 CIN2+ 检出敏感性。
  • 在≥50 岁、高级别细胞学及住院医师操作时,Swedescore 敏感性优势更明显。
  • 结果应结合两种阴道镜方法间的基线不平衡谨慎解读。

核心结论

  • 系统使用 Swedescore 较传统阴道镜略微提高 CIN2+ 检出准确性,但需考虑两组基线不平衡。

研究设计与样本

  • 多中心非随机临床研究,纳入 929 名 23–65 岁转诊阴道镜且转化区可见(1 型和 2 型)的女性,Swedescore 组 534 例、传统组 395 例。
  • 所有女性均取四处宫颈活检,以全部四处活检中最严重诊断(CIN2+)为金标准,计算敏感性、特异性、阳性预测值和阴性预测值及 95% 置信区间。

主要发现

  • Swedescore 组 CIN2+ 敏感性 84.7%、特异性 37.3%、阳性预测值 47.6%、阴性预测值 78.3%,传统组分别为 77.8%、30.9%、43.9%、66.7%。
  • 在≥50 岁女性中,Swedescore 组 CIN2+ 敏感性 92.9%,传统组 62.5%。
  • 在高级别细胞学女性中,Swedescore 组 CIN2+ 敏感性 92.4%,传统组 83.2%。
  • 由住院医师操作阴道镜时,Swedescore 组 CIN2+ 敏感性 91.8%,传统组 70.6%。
  • 无论 HPV 疫苗接种状态和筛查方法如何,Swedescore 的表现均略优于传统方法。

临床怎么用

  • 对非专家阴道镜医师,系统使用 Swedescore 可能有助于减少 CIN2+ 检出差异。
  • 在≥50 岁、高级别细胞学或住院医师操作场景下,可考虑优先使用 Swedescore 系统评分法。

局限性

  • 研究为非随机设计,两种阴道镜方法间存在基线不平衡,结果解读需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Our findings may help reduce variability in the detection of CIN2+ among non-expert colposcopists, since the systematic use of Swedescore slightly improved CIN2+ detection compared to the conventional method. However, these findings should be interpreted considering baseline imbalances between the two colposcopy methods. Abstract Introduction Globally, colposcopy is often performed by non-experts with no certification or routine use of colposcopic scoring tools. A systematic colposcopic scoring tool, the Swedescore, has been developed to enhance the detection rate of cervical intraepithelial neoplasia grade 2 or worse (CIN2+). We aimed to compare the diagnostic accuracy of two colposcopy methods (systematic use of the Swedescore versus conventional colposcopy) for detecting CIN2+. Material and Methods This multicenter, non-randomized clinical study included women (23–65 years) referred for colposcopy and with a visible transformation zone (type 1 and 2). Colposcopy was performed using the systematic scoring tool, Swedescore, or the conventional method. All women had four cervical biopsies collected. Colposcopists collected lesion-directed biopsies (target biopsies) from abnormal areas with or without non-lesion-directed biopsies (random biopsies) from areas that appeared normal. The gold standard was the most severe diagnosis (CIN2+) based on all four biopsies. The primary outcome was CIN2+. We calculated sensitivity (SN), specificity (SP), positive predictive value (PPV), and negative predictive value (NPV) with 95% confidence intervals and compared results between the two methods. Results were stratified by age, body mass index (BMI), human papillomavirus (HPV) vaccination status, screening method, index cytology, index HPV type, and colposcopists. Clinical Trial Registration ClinicalTrials.gov NCT05870787. Results Among 929 women included (Swedescore: 534, conventional: 395), the diagnostic accuracy for the detection of CIN2+ was slightly higher with the Swedescore compared to the conventional method (SN: 84.7% vs. 77.8%, SP: 37.3% vs. 30.9%, PPV: 47.6% vs. 43.9%, NPV: 78.3% vs. 66.7%). Sensitivity for CIN2+ was significantly higher with the Swedescore compared to the conventional method in women ≥50 years (92.9% vs. 62.5%), those with high-grade cytology (92.4% vs. 83.2%), and when colposcopy was performed by residents (91.8% vs. 70.6%). Regardless of HPV vaccination status and screening method, the Swedescore performed slightly better than the convent

来源:Acta Obstetricia et Gynecologica Scandinavica,查看原文。版权归原作者所有。

引用

  1. Acta Obstetricia et Gynecologica Scandinavica:Diagnostic accuracy of a systematic approach using Swedescore versus conventional colposcopy for the detection of cervical intraepithelial neoplasia grade 2 or worse: A multicenter, non‐randomized clinical study

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。